Alert
Close

Last chance – give now. Before 2014 ends, help struggling seniors. Donate

HIGHLIGHTS

Open

AARP VETERAN MEMBERSHIP

Military and Veterans Discount

CONTESTS AND SWEEPS

AARP REALPAD

Introducing RealPad by AARP

AUTO BUYING PROGRAM

AARP Auto Buying Program

Download the ipad App

AARP-iPad-ePub-app

DRIVER SAFETY

Piggy bank on the road - AARP Driver Safety

Take the new AARP Smart Driver Course!

KEEP BRAIN ACTIVE!

AARP Games - Play Now!

AARP BOOKS

Planning for Long-Term Care for Dummies

Get expert advice on planning for your own or a relative’s future care needs.

Webinars

Learn From the Experts

Sign up now for an upcoming webinar or find materials from a past session.

Learning centers

Get smart strategies for managing health conditions.

 

Arthritis

Heart Disease

Diabetes

Most Popular

Viewed

Your Health

Alzheimer’s: A New Theory

New research appears to upend our current understanding of the causes of Alzheimer’s disease, and may lead to a whole new approach to finding a cure for the devastating dementia.

The controversial new theory gaining traction in the scientific community is that in Alzheimer’s disease the brain is destroyed not by sticky plaques—long held to be the culprit—but by free-floating clumps of protein.

In fact, the sticky plaques that surround the brain cells of those with Alzheimer’s may be the body’s way of protecting against these toxic clumps.

For the last 20 years, following the prevailing theory that sticky plaques cause Alzheimer’s disease, drug developers have been targeting those plaques in their search for a cure.

But recently published studies on mice and rats may prove to be the tipping point that takes research in a new direction. Many scientists now believe clumps of amyloid beta protein called oligomers are the main players in the rogue process that attacks the brain.

“Plaques are no longer where the action is,” says Sam Gandy, M.D., of the Alzheimer’s Disease Research Center at Mount Sinai School of Medicine in New York.

Gandy’s work builds on several years of research that has been moving toward this new theory. And if the theory is correct, then drugs that target plaques—as many of the most promising medications have done in the past few years—may not help people who have the disease. They could even make them worse. This research is key. About 5.1 million Americans have Alzheimer’s, and that number will grow as boomers age.

Gandy’s work with specially engineered mice—which developed Alzheimer’s though they had only clumps of the oligomers and no plaques in their brains—“is the final experiment that’s making the whole field turn around,” says Andrew Dillin, a scientist who studies aging and the brain at the Salk Institute of California. The role amyloid beta plays in the development of the disease was a hot topic at the international Alzheimer’s conference in Hawaii this summer.

While the development is exciting, William Thies, the Alzheimer’s Association’s chief medical officer, cautions that the leap from mice to men is a long one and that Gandy’s experiments need to be duplicated by other scientists in other labs before drug companies invest billions of dollars to create new medicines that target the oligomers.

Gandy’s new study looked at the most basic science of the disease in a very different way.

“Alzheimer’s seems to be caused by the buildup in the brain of clumps of material that are formed by the breakdown of protein,” Gandy says.

He now thinks the oligomers, not plaques, cause the loss of memory and reason that characterize Alzheimer’s. Gandy and colleagues published their work in the Annals of Neurology in April.

Dillin, of the Salk Institute, started pursuing the oligomer theory several years ago. Then, the idea was so controversial, Dillin says, that some scientists would walk out of the room when he made his presentation at conferences. Now, he says, many of the top researchers in the field are convinced.

Compelling experiment

Alzheimer’s disease is characterized by two main elements—the sticky plaques that form outside the brain cells, and tangles of another protein, tau, that twist around the inside of the cells. Both are thought to play a role in the progression of the disease.

Scientists noticed the buildup of the sticky plaques in the brains of people with Alzheimer’s disease 100 years ago. And although there has been some debate, the prevailing science has held that sticky plaques and tau tangles cause the damage.

Topic Alerts

You can get weekly email alerts on the topics below. Just click “Follow.”

Manage Alerts

Processing

Please wait...

progress bar, please wait

Tell Us WhatYou Think

Please leave your comment below.

Discounts & Benefits

From companies that meet the high standards of service and quality set by AARP.

AARP membership discount Man trying on eyeglasses at optometrists smiling

Members save up to 60% on eye exams and 30% on glasses at LensCrafters.

Grandson (8-9) whispering to grandfather, close-up

Members can save 20% on hearing aids with the AARP® Hearing Care Program provided by HearUSA.

member benefits adt companion

Members save on new installation of a ADT Companion Service® personal emergency response system.

Member Benefits

Join or renew today! AARP members receive exclusive member benefits & affect social change.

Rewards for Good

Your Points Balance:

Learn More

Earn points for completing free online activities designed to enrich your life.

Find more ways to earn points

Redeem your points to save on merchandise, travel, and more.

Find more ways to redeem points